State Street Ends Substantial Holding in Telix Pharmaceuticals
Company Announcements

State Street Ends Substantial Holding in Telix Pharmaceuticals

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

Telix Pharmaceuticals Ltd. has announced that State Street Global Advisors ceased to be a substantial holder on August 5, 2024. This update follows the previous substantial holding notice provided to the company on July 26, 2024. Details of the changes in relevant interests and associations concerning voting securities are disclosed in compliance with the Corporations Act 2001.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Gains from New CMS Reimbursement Policy
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Gains FDA Priority Review for Cancer Imaging Agent
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals to Release Shares from Escrow
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App